medroxyprogesterone acetate has been researched along with Cancer, Second Primary in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hensiek, AE; Hill, JT; Kellerman, AJ | 1 |
2 other study(ies) available for medroxyprogesterone acetate and Cancer, Second Primary
Article | Year |
---|---|
Estrogen replacement therapy in women with previously treated breast cancer. ACOG Committee Opinion: Committee on Gynecologic Practice Number 135-April 1994.
Topics: Adult; Breast Neoplasms; Case-Control Studies; Delayed-Action Preparations; DNA, Neoplasm; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Norgestrel; Postmenopause; Risk Factors; RNA, Neoplasm; Tamoxifen | 1994 |
Spontaneous regression of a solitary cerebral metastases in renal carcinoma followed by meningioma development under medroxyprogesterone acetate therapy.
Topics: Adult; Antineoplastic Agents, Hormonal; Brain Neoplasms; Carcinoma, Renal Cell; Follow-Up Studies; Humans; Kidney Neoplasms; Male; Medroxyprogesterone Acetate; Meningioma; Neoplasm Regression, Spontaneous; Neoplasms, Second Primary | 2000 |